Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Study shows antipsychotic medication increases death risk in patients with Parkinson's disease psychosis

Study shows antipsychotic medication increases death risk in patients with Parkinson's disease psychosis

Mylan releases generic version of Invega in the U.S.

Mylan releases generic version of Invega in the U.S.

Two-drug combination relieves depression in older adults

Two-drug combination relieves depression in older adults

ProPhase partners with Multi Health Systems to standardize electronic adaptations of PANSS

ProPhase partners with Multi Health Systems to standardize electronic adaptations of PANSS

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

Special issue provides update on mental health diagnosis and treatment of older adults

Special issue provides update on mental health diagnosis and treatment of older adults

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Brain scans may help predict patients' response to antipsychotic drug treatment

Brain scans may help predict patients' response to antipsychotic drug treatment

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

15th Annual Geriatric Health Care Symposium now open for registration

15th Annual Geriatric Health Care Symposium now open for registration

Diagnosing psychiatric disorder may not be as important as prescribing effective treatment

Diagnosing psychiatric disorder may not be as important as prescribing effective treatment

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Study identifies trends in use of antipsychotic medications in young people in the U.S.

Study identifies trends in use of antipsychotic medications in young people in the U.S.

Use of antipsychotic drugs more common in boys than girls, research shows

Use of antipsychotic drugs more common in boys than girls, research shows

FAU awarded $2.1 million to examine effectiveness of antipsychotic medication for schizophrenia

FAU awarded $2.1 million to examine effectiveness of antipsychotic medication for schizophrenia

Long-acting injectable antipsychotic medication benefits people with schizophrenia

Long-acting injectable antipsychotic medication benefits people with schizophrenia

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

New data shows psychotropic medication use among Medicaid-enrolled foster children in Pennsylvania

New data shows psychotropic medication use among Medicaid-enrolled foster children in Pennsylvania

HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.